(KBIO) - Earnings & Price History

KBIO: - 2.19, $0.00M, 0.46 (26.81%)

Sector: Healthcare - Industry: Biotechnology

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, develops monoclonal antibody therapeutics for the treatment of cancer in the United States. Its lead product candidate is benznidazole for the treatment of Chagas disease, a parasitic illness that can lead to long-term heart, intestinal, and neurological problems. The company is also developing proprietary monoclonal antibodies, including lenzilumab, which is in Phase I clinical trial in patients with chronic myelomonocytic leukemia; and ifabotuzumab that has completed Phase I/II clinical trial in multiple hematologic malignancies, as well as evaluating further studies of ifabotuzumab in rare solid tumors, such as glioblastoma, other brain cancers in children, and rare hematologic cancer indications. In addition, it has an additional drug candidate, KB001-A, a recombinant, PEGylated, anti-Pseudomonas PcrV high-affinity Fab anti

Past KBIO reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2015-11-06BMO-1.450.921.931.080.81.08-44.04%▲-14.81%-52.33%660.90K
2015-11-05BMO-1.451.931.881.971.861.984.79%▲-2.03%2.66%30.31K
2015-11-04BMO-1.451.881.931.891.841.97-2.07%▲-0.53%-2.59%37.04K
2015-08-10BMO-1.682.051.871.871.872.079.63%9.63%51.73K
2015-08-07BMO-1.681.8721.981.831.98-1.00%-5.56%-6.50%81.35K
2015-08-06BMO-1.682.12992.032.052.052.12990.99%3.90%4.92%800
2015-08-05BMO-1.682.032.092.12.032.140.48%-3.33%-2.87%26.81K
2015-05-08-0.3
2015-05-07-0.30.50.50.510.50.512.00%-1.96%173.56K
2015-05-06-0.30.50.5060.5190.480.532.57%-3.66%-1.19%148.81K
2014-11-11Kalobios Pharma-0.34-0.242.111.982.0522.153.54%▲2.93%6.57%212.80K
2014-08-18Kalobios Pharma-0.34-0.31.591.591.521.361.61-4.40%4.61%144.40K
2014-05-13Kalobios Pharma-0.34-0.321.951.931.91.892.03-1.55%2.63%1.04%129.90K
2014-03-26Kalobios Pharma-0.41-0.252.732.842.832.662.89-0.35%-3.53%-3.87%159.30K
2013-11-18Kalobios Pharma-0.49-0.474.054.084.094.014.10.25%▲-0.98%-0.74%108.00K
2013-08-20Kalobios Pharma-0.41-0.495.135.45.45.135.41-5.00%-5.00%16.50K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades